Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization

References

• Powell SN, Kachnic LA. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 2003; 22:5784-91; PMID:12947386; http://dx.doi.org/10.1038/sj.onc.1206678
   PubMed Web of Science ®Google Scholar
• Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006; 34:1416-26; PMID:16522651; http://dx.doi.org/10.1093/nar/gkl010
   PubMed Web of Science ®Google Scholar
• Prakash R, Zhang Y, Feng W, Jasin M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol 2015; 7:a016600; PMID:25833843; http://dx.doi.org/10.1101/cshperspect.a016600
   PubMed Web of Science ®Google Scholar
• King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302:643-6; PMID:14576434; http://dx.doi.org/10.1126/science.1088759
   PubMed Web of Science ®Google Scholar
• Metcalfe K, Lubinski J, Lynch HT, Ghadirian P, Foulkes WD, Kim-Sing C, Neuhausen S, Tung N, Rosen B, Gronwald J, et al. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. J Natl Cancer Inst 2010; 102:1874-8; PMID:21098759; http://dx.doi.org/10.1093/jnci/djq443
   PubMedGoogle Scholar
• Clark SL, Rodriguez AM, Snyder RR, Hankins GD, Boehning D. Structure-Function Of The Tumor Suppressor BRCA1. Comput Struct Biotechnol J 2012; 1:1-8; PMID:22737296
   PubMedGoogle Scholar
• Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 1996; 14:430-40; PMID:8944023; http://dx.doi.org/10.1038/ng1296-430
   PubMed Web of Science ®Google Scholar
• Brzovic PS, Meza JE, King MC, Klevit RE. BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions. J Biol Chem 2001; 276:41399-406; PMID:11526114; http://dx.doi.org/10.1074/jbc.M106551200
   PubMed Web of Science ®Google Scholar
• Yu X, Chini CC, He M, Mer G, Chen J. The BRCT domain is a phospho-protein binding domain. Science 2003; 302:639-42; PMID:14576433; http://dx.doi.org/10.1126/science.1088753
   PubMed Web of Science ®Google Scholar
• Mohammad DH, Yaffe MB. 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. DNA Repair (Amst) 2009; 8:1009-17; PMID:19481982; http://dx.doi.org/10.1016/j.dnarep.2009.04.004
   PubMed Web of Science ®Google Scholar
• King MC. “The race” to clone BRCA1. Science 2014; 343:1462-5; PMID:24675952; http://dx.doi.org/10.1126/science.1251900
   PubMed Web of Science ®Google Scholar
• Humphrey JS, Salim A, Erdos MR, Collins FS, Brody LC, Klausner RD. Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc Natl Acad Sci U S A 1997; 94:5820-5; PMID:9159158; http://dx.doi.org/10.1073/pnas.94.11.5820
   PubMed Web of Science ®Google Scholar
• Monteiro AN, Humphrey JS. Yeast-based assays for detection and characterization of mutations in BRCA1. Breast Dis 1998; 10:61-70; PMID:15687549; http://dx.doi.org/10.3233/BD-1998-101-208
   PubMedGoogle Scholar
• Coyne RS, McDonald HB, Edgemon K, Brody LC. Functional characterization of BRCA1 sequence variants using a yeast small colony phenotype assay. Cancer Biol Ther 2004; 3:453-7; PMID:15004537; http://dx.doi.org/10.4161/cbt.3.5.809
   PubMed Web of Science ®Google Scholar
• Millot GA, Carvalho MA, Caputo SM, Vreeswijk MP, Brown MA, Webb M, Rouleau E, Neuhausen SL, Hansen T, Galli A, et al. A guide for functional analysis of BRCA1 variants of uncertain significance. Hum Mutat 2012; 33:1526-37; PMID:22753008; http://dx.doi.org/10.1002/humu.22150
   PubMed Web of Science ®Google Scholar
• Jhuraney A, Velkova A, Johnson RC, Kessing B, Carvalho RS, Whiley P, Spurdle AB, Vreeswijk MP, Caputo SM, Millot GA, et al. BRCA1 Circos: a visualisation resource for functional analysis of missense variants. J Med Genet 2015; 52:224-30; PMID:25643705; http://dx.doi.org/10.1136/jmedgenet-2014-102766
   PubMed Web of Science ®Google Scholar
• Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem 2001; 276:14537-40; PMID:11278247; http://dx.doi.org/10.1074/jbc.C000881200
   PubMed Web of Science ®Google Scholar
• Mallery DL, Vandenberg CJ, Hiom K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. Embo J 2002; 21:6755-62; PMID:12485996; http://dx.doi.org/10.1093/emboj/cdf691
   PubMed Web of Science ®Google Scholar
• Caligo MA, Bonatti F, Guidugli L, Aretini P, Galli A. A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance. Hum Mutat 2009; 30:123-33; PMID:18680205; http://dx.doi.org/10.1002/humu.20817
   PubMed Web of Science ®Google Scholar
• Dever SM, Golding SE, Rosenberg E, Adams BR, Idowu MO, Quillin JM, Valerie N, Xu B, Povirk LF, Valerie K. Mutations in the BRCT binding site of BRCA1 result in hyper-recombination. Aging (Albany NY) 2011; 3:515-32; PMID:21666281; http://dx.doi.org/10.18632/aging.100325
   PubMedGoogle Scholar
• Woods NT, Baskin R, Golubeva V, Jhuraney A, De-Gregoriis G, Vaclova T, Goldgar DE, Couch FJ, Carvalho MA, Iversen ES, et al. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance. Npj Genomic Medicine 2016; 1:16001; http://dx.doi.org/10.1038/npjgenmed.2016.1
   Google Scholar
• Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, Ota A, Wong HY, Konishi Y, Karakas B, et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc Natl Acad Sci U S A 2011; 108:17773-8; PMID:21987798; http://dx.doi.org/10.1073/pnas.1110969108
   PubMed Web of Science ®Google Scholar
• Lindor NM, Guidugli L, Wang X, Vallee MP, Monteiro AN, Tavtigian S, Goldgar DE, Couch FJ. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat 2012; 33:8-21; PMID:21990134; http://dx.doi.org/10.1002/humu.21627
   PubMed Web of Science ®Google Scholar
• Tavtigian SV, Greenblatt MS, Goldgar DE, Boffetta P. Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group. Hum Mutat 2008; 29:1261-4; PMID:18951436; http://dx.doi.org/10.1002/humu.20903
   PubMed Web of Science ®Google Scholar
• Henderson BR. Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking. Bioessays 2005; 27:884-93; PMID:16108063; http://dx.doi.org/10.1002/bies.20277
   PubMed Web of Science ®Google Scholar
• Au WW, Henderson BR. The BRCA1 RING and BRCT domains cooperate in targeting BRCA1 to ionizing radiation-induced nuclear foci. J Biol Chem 2005; 280:6993-7001; PMID:15569676; http://dx.doi.org/10.1074/jbc.M408879200
   PubMed Web of Science ®Google Scholar
• Au WW, Henderson BR. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage. Cell Signal 2007; 19:1879-92; PMID:17531442; http://dx.doi.org/10.1016/j.cellsig.2007.04.010
   PubMed Web of Science ®Google Scholar
• Millot GA, Berger A, Lejour V, Boule JB, Bobo C, Cullin C, Lopes J, Stoppa-Lyonnet D, Nicolas A. Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast. Hum Mutat 2011; 32:1470-80; PMID:21922593; http://dx.doi.org/10.1002/humu.21608
   PubMed Web of Science ®Google Scholar
• Loeb LA. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer 2011; 11:450-7; PMID:21593786; http://dx.doi.org/10.1038/nrc3063
   PubMed Web of Science ®Google Scholar
• Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, Easton DF, Pharoah PP. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 2002; 62:3052-7; PMID:12036913
   PubMed Web of Science ®Google Scholar
• Adem C, Soderberg CL, Hafner K, Reynolds C, Slezak JM, Sinclair CS, Sellers TA, Schaid DJ, Couch F, Hartmann LC, et al. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers. Genes Chromosomes Cancer 2004; 41:1-11; PMID:15236312; http://dx.doi.org/10.1002/gcc.20057
   PubMed Web of Science ®Google Scholar
• Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000; 14:927-39; PMID:10783165
   PubMed Web of Science ®Google Scholar
• Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res 2008; 18:85-98; PMID:18157157; http://dx.doi.org/10.1038/cr.2007.115
   PubMed Web of Science ®Google Scholar
• Peltomaki P. DNA mismatch repair and cancer. Mutat Res 2001; 488:77-85; PMID:11223406; http://dx.doi.org/10.1016/S1383-5742(00)00058-2
   PubMed Web of Science ®Google Scholar
• Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003; 21:1174-9; PMID:12637487; http://dx.doi.org/10.1200/JCO.2003.04.060
   PubMed Web of Science ®Google Scholar
• Kunkel TA, Erie DA. DNA mismatch repair. Annu Rev Biochem 2005; 74:681-710; PMID:15952900; http://dx.doi.org/10.1146/annurev.biochem.74.082803.133243
   PubMed Web of Science ®Google Scholar
• Muller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 2002; 20:102-9; PMID:11852992; http://dx.doi.org/10.1081/CNV-120000371
   PubMed Web of Science ®Google Scholar
• Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001; 68:118-27; PMID:11112663; http://dx.doi.org/10.1086/316942
   PubMed Web of Science ®Google Scholar
• Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 2009; 75:141-9; PMID:19215248; http://dx.doi.org/10.1111/j.1399-0004.2008.01125.x
   PubMed Web of Science ®Google Scholar
• Engel C, Loeffler M, Steinke V, Rahner N, Holinski-Feder E, Dietmaier W, Schackert HK, Goergens H, von Knebel Doeberitz M, Goecke TO, et al. Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 2012; 30:4409-15; PMID:23091106; http://dx.doi.org/10.1200/JCO.2012.43.2278
   PubMed Web of Science ®Google Scholar
• Malander S, Rambech E, Kristoffersson U, Halvarsson B, Ridderheim M, Borg A, Nilbert M. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer. Gynecol Oncol 2006; 101:238-43; PMID:16360201; http://dx.doi.org/10.1016/j.ygyno.2005.10.029
   PubMed Web of Science ®Google Scholar
• Watson P, Lynch HT. Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 2001; 1:57-60; PMID:14574017; http://dx.doi.org/10.1023/A:1011590617833
   PubMedGoogle Scholar
• Polaczek P, Putzke AP, Leong K, Bitter GA. Functional genetic tests of DNA mismatch repair protein activity in Saccharomyces cerevisiae. Gene 1998; 213:159-67; PMID:9630599; http://dx.doi.org/10.1016/S0378-1119(98)00150-4
   PubMed Web of Science ®Google Scholar
• Ellison AR, Lofing J, Bitter GA. Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 2001; 10:1889-900; PMID:11555625; http://dx.doi.org/10.1093/hmg/10.18.1889
   PubMed Web of Science ®Google Scholar
• Aldred PM, Borts RH. Humanizing mismatch repair in yeast: towards effective identification of hereditary non-polyposis colorectal cancer alleles. Biochem Soc Trans 2007; 35:1525-8; PMID:18031259; http://dx.doi.org/10.1042/BST0351525
   PubMed Web of Science ®Google Scholar
• Gammie AE, Erdeniz N, Beaver J, Devlin B, Nanji A, Rose MD. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae. Genetics 2007; 177:707-21; PMID:17720936
   PubMedGoogle Scholar
• Maresca L, Spugnesi L, Lodovichi S, Cozzani C, Naccarato AG, Tancredi M, Collavoli A, Falaschi E, Rossetti E, Aretini P, et al. MSH2 role in BRCA1-driven tumorigenesis: A preliminary study in yeast and in human tumors from BRCA1-VUS carriers. Eur J Med Genet 2015; 58:531-9; PMID:26381082; http://dx.doi.org/10.1016/j.ejmg.2015.09.005
   PubMed Web of Science ®Google Scholar
• Sgagias MK, Wagner KU, Hamik B, Stoeger S, Spieker R, Huber LJ, Chodosh LA, Cowan KH. Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS. Cell Cycle 2004; 3:1451-6; PMID:15492509; http://dx.doi.org/10.4161/cc.3.11.1211
   PubMed Web of Science ®Google Scholar
• Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997; 90:425-35; PMID:9267023; http://dx.doi.org/10.1016/S0092-8674(00)80503-6
   PubMed Web of Science ®Google Scholar
• Brodie KM, Henderson BR. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage. Cell Signal 2010; 22:291-302; PMID:19796682; http://dx.doi.org/10.1016/j.cellsig.2009.09.034
   PubMed Web of Science ®Google Scholar
• Henderson BR. Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking. Bioessays 2005; 27:884-93; PMID:16108063; http://dx.doi.org/10.1002/bies.20277
   PubMed Web of Science ®Google Scholar
• Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 2010; 11:138-48; PMID:20029420; http://dx.doi.org/10.1038/nrm2831
   PubMed Web of Science ®Google Scholar
• Venkitaraman AR. Cancer suppression by the chromosome custodians, BRCA1 and BRCA2. Science 2014; 343:1470-5; PMID:24675954; http://dx.doi.org/10.1126/science.1252230
   PubMed Web of Science ®Google Scholar
• Lundin C, North M, Erixon K, Walters K, Jenssen D, Goldman AS, Helleday T. Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks. Nucleic Acids Res 2005; 33:3799-811; PMID:16009812; http://dx.doi.org/10.1093/nar/gki681
   PubMed Web of Science ®Google Scholar
• Galli A, Schiestl RH. Cell division transforms mutagenic lesions into deletion-recombinagenic lesions in yeast cells. Mutat Res 1999; 429:13-26; PMID:10434021; http://dx.doi.org/10.1016/S0027-5107(99)00097-4
   PubMed Web of Science ®Google Scholar
• Galli A, Cervelli T, Schiestl RH. Characterization of the hyperrecombination phenotype of the pol3-t mutation of Saccharomyces cerevisiae. Genetics 2003; 164:65-79; PMID:12750321
   PubMed Web of Science ®Google Scholar
• Kass EM, Jasin M. Collaboration and competition between DNA double-strand break repair pathways. FEBS Lett 2010; 584:3703-8; PMID:20691183; http://dx.doi.org/10.1016/j.febslet.2010.07.057
   PubMed Web of Science ®Google Scholar
• Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res 2008; 18:99-113; PMID:18166982; http://dx.doi.org/10.1038/cr.2008.1
   PubMed Web of Science ®Google Scholar
• Westmoreland TJ, Olson JA, Saito WY, Huper G, Marks JR, Bennett CB. Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeast. J Surg Res 2003; 113:62-73; PMID:12943812; http://dx.doi.org/10.1016/S0022-4804(03)00155-0
   PubMed Web of Science ®Google Scholar
• Bennett CB, Westmoreland TJ, Verrier CS, Blanchette CA, Sabin TL, Phatnani HP, Mishina YV, Huper G, Selim AL, Madison ER, et al. Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction. PLoS ONE 2008; 3:e1448; http://dx.doi.org/10.1371/journal.pone.0001448
   Google Scholar
• Belgareh N, Doye V. Dynamics of nuclear pore distribution in nucleoporin mutant yeast cells. J Cell Biol 1997; 136:747-59; PMID:9049242; http://dx.doi.org/10.1083/jcb.136.4.747
   PubMed Web of Science ®Google Scholar
• Gietz RD, Schiestl RH. High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc 2007; 2:31-4; PMID:17401334; http://dx.doi.org/10.1038/nprot.2007.13
   PubMed Web of Science ®Google Scholar
• Schiestl RH, Igarashi S, Hastings PJ. Analysis of the mechanism for reversion of a disrupted gene. Genetics 1988; 119:237-47; PMID:2840335
   PubMed Web of Science ®Google Scholar
• Schiestl RH, Gietz RD, Mehta RD, Hastings PJ. Carcinogens induce intrachromosomal recombination in yeast. Carcinogenesis 1989; 10:1445-55; PMID:2665967; http://dx.doi.org/10.1093/carcin/10.8.1445
   PubMed Web of Science ®Google Scholar
• Schiestl RH. Nonmutagenic carcinogens induce intrachromosomal recombination in yeast. Nature 1989; 337:285-8; PMID:2643057; http://dx.doi.org/10.1038/337285a0
   PubMed Web of Science ®Google Scholar